Schedule 13G ownership disclosure
APRICUS BIOSCIENCES INC
Security class unavailable · CUSIP: 03832V307
Event date: 2017-04-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-17-004514
- Form type
- SC 13G
- Filer
- SEELOS THERAPEUTICS, INC.
- CIK
- CIK 1017491
- Filed
- May 02, 2017
- Reporting period
- Apr 26, 2017
- Description
- Schedule 13G beneficial ownership